Cardiomyopathy Perspective

 
 
  • What NFL, NBA, and MLB COVID Protocols Taught Us   Drs Robert Glatter, John DiFiori, James Kinderknecht, and Kathryn McElheny discuss protocols and experiences related to medical care of athletes in the NBA, NFL, and MLB during the COVID-19 pandemic.
  • No Obstruction Shouldn't Mean No Diagnosis: HARP-MINOCA   A new study finds that multimodal imaging can reveal the cause of most MINOCA. Lead investigator Harmony Reynolds shares the details from her AHA presentation with Michelle O'Donoghue.
  • Could RAS Dysfunction Explain COVID's Effects? Dr Andrew Wilner speaks with the researcher proposing that the renin-angiotensin system is the reason for COVID-19's complex symptoms.
  • 2020 Guideline Changes: Return-to-Play, Rooming In COVID has necessitated some changes for non-COVID areas of practice. Here are two guideline changes that every pediatric clinician should know.
  • Oct 23 2020 This Week in Cardiology   COVID, tocilizumab, hypertrophic cardiomyopathy, cerebral microbleeds, and surrogate endpoints are the topics discussed by John Mandrola, MD, in this week’s podcast
  • ECG Challenge: Abdominal Pain, Diarrhea in Heart Disease Patient A man with hypertension and coronary artery disease presents to the emergency department with abdominal pain and diarrhea. What does his ECG show?
  • Heart Failure Biomarkers in COVID-19 Cardiac biomarkers may be abnormal in patients with COVID-19. Here a review of the interpretation of these markers in the context of the novel coronavirus.
  • Surgery Still Best Option in Obstructive HCM Promising results for a novel drug should not push surgical options aside for patients with obstructive hypertrophic cardiomyopathy, argue two surgeons.
  • HFpEF Management: 5 Things to Know Although proven medical therapies for HFpEF are few, a stepwise set of management practices can help optimize care for patients with this condition.
  • Heart Failure Highlights From ESC 2020   Dr Akshay Desai, of Harvard Medical School, reviews key studies on heart failure, presented at the European Society of Cardiology (ESC) Congress 2020, which was held as a virtual conference.
  • What Do ISCHEMIA and CIAO Tell Us About CVD?   ISCHEMIA and CIAO provide insight on nonobstructive ischemia. Drs Taub and Reynolds discuss how the findings should be incorporated into practice.
  • Mandrola Previews the Virtual ESC 2020 Trials on SGLT2 inhibitors, rhythm control in AF, and a few drugs he’s never heard of are among John Mandrola’s picks from the upcoming European Society of Cardiology Congress.
  • Don't Let Dubious Science Cancel College Football College football is in pandemic limbo. Among the concerns are scare stories about corona-related heart inflammation in recovered patients. Cardiologist Anish Koka finds the data less than convincing.
  • Cookbook Medicine Won't Cut It With New Drugs for HFrEF   The plethora of new drugs means one size will not fit all patients with HFrEF. Clinicians will have to tailor their strategies, says Ileana Pina, MD.
  • Preparticipation CV Screening: Who Gets the Red Card?   Which cardiac conditions are disqualifying for kids who play sports? From hypertrophic cardiomyopathy to heart transplant, Mayo Clinic's Jonathan Johnson and Bernard Gersh have answers that may surprise you.
  • Sodium Restriction in Heart Failure Does reducing dietary sodium affect clinical outcomes in patients with heart failure? A look at the conflicting evidence.
  • Alcohol and Cardioprotection: Enduring Truth or Myth? The WHO calls alcohol a toxic substance, yet cardiology guidelines give tacit approval to moderate drinking. Cardiologist and epidemiologist Christopher Labos reviews recent data to see if that should change.
  • Cardiologists, Oncologists Desperately Need Your Help   Oncologists and cardiologists need to collaborate to optimize outcomes for patients with cancer and long-term survivors. Will a new subspecialty emerge?
  • Emergency in a Dilated Cardiomyopathy Patient A 76-year-old woman with dilated cardiomyopathy has a rapid heart rate associated with hypotension. What does her ECG show?
  • Smoldering Multiple Myeloma: Dangerous Precursor: What the Future Brings   Hematologists look to the future and ask: Given the growing array of therapeutic options, which strategies will become standard practice in smoldering myeloma?